A Biochemical Society Focused Meeting
The aim of this focused meeting is to explore the mechanisms of BMP signal transduction and regulation of signalling, and discuss how genetic and epigenetic alterations result in aberrant signalling and how this leads to cancer. The BMP signalling pathway is a key therapeutic target and we will consider how to manipulate the pathway with small molecules or biologics. This conference will bring together researchers from academe and industry, and will be a great opportunity for those working on BMP signalling, cancer, stem cells, structural biology and drug discovery to share data and interact in a vibrant, but informal environment.
- Mechanisms of BMP signalling
- Deregulation of BMP signalling in cancer and therapeutic approaches
- Genetic and epigenetic alterations in BMP pathway components
- BMP signalling in disease
Topics covered in this meeting will be published in Biochemical Society Transactions
Abstract deadline: extended - 15 January 2016.
Abstract submission is now closed.
Earlybird registration deadline: 12 January 2016.
Registration is now closed.
Oral communication slots are available at this meeting. All attendees, particularly researchers in the early stages of their career, are invited to submit a poster abstract for consideration as an oral communication.
Flash poster presentations are also available in the programme. Poster abstracts will be considered for the flash presentations.
Student Bursaries and Full and Early Career Bursaries are available for this meeting.
Not a member of the Biochemical Society? Join today and save up to £100 on your registration fee.
Invited speakers are:
Peter ten Dijke (Leiden University)
Hilary Ashe (University of Manchester)
Christian Siebold (University of Oxford)
David Shields (Pfizer)
Charles Hong (Vanderbilt University)
James DiRenzo (Dartmouth Medical School)
Helen Wheadon (University of Glasgow)
Filippo Giancotti (Memorial Sloan Kettering Cancer Center)
Simon Leedham (University of Oxford)
Chris Jones (ICR)
An Zwijsen (VIB)
Wei Li (University of Cambridge)
View the scientific programme here.